BERGAGGIO, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 359
EU - Europa 333
AS - Asia 114
AF - Africa 4
OC - Oceania 2
SA - Sud America 2
Totale 814
Nazione #
US - Stati Uniti d'America 355
IT - Italia 240
CN - Cina 60
SG - Singapore 28
SE - Svezia 18
IE - Irlanda 15
UA - Ucraina 13
DE - Germania 8
GB - Regno Unito 7
AT - Austria 6
FR - Francia 6
JP - Giappone 6
CA - Canada 4
FI - Finlandia 4
KR - Corea 4
BE - Belgio 3
ID - Indonesia 3
IN - India 3
RO - Romania 3
SN - Senegal 3
VN - Vietnam 3
CH - Svizzera 2
ES - Italia 2
HK - Hong Kong 2
PL - Polonia 2
AU - Australia 1
BR - Brasile 1
BY - Bielorussia 1
CO - Colombia 1
CZ - Repubblica Ceca 1
HR - Croazia 1
IR - Iran 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PH - Filippine 1
TH - Thailandia 1
TN - Tunisia 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 814
Città #
Torino 87
Turin 58
Chandler 47
Fairfield 25
Novara 25
Santa Clara 23
Singapore 23
Beijing 22
Ashburn 19
Cambridge 19
Woodbridge 18
Dublin 15
Wilmington 13
Houston 12
Jacksonville 10
New York 10
Bologna 9
Nyköping 9
Seattle 9
Fremont 7
Columbus 6
Guangzhou 6
Vienna 6
Ann Arbor 5
Jinan 5
Medford 5
Latina 4
Ottawa 4
Pisa 4
Princeton 4
Rome 4
Boardman 3
Boston 3
Brussels 3
Dearborn 3
Dong Ket 3
Durham 3
Heidelberg 3
Jakarta 3
Nanjing 3
Redwood City 3
San Diego 3
San Francisco 3
San Mateo 3
Suzhou 3
Cadoneghe 2
Flushing 2
Galati 2
Geneve 2
Lecce 2
London 2
Serravalle Scrivia 2
Shanghai 2
Upper Marlboro 2
Villeurbanne 2
Warsaw 2
Xian 2
Yuba City 2
Zhengzhou 2
Ankara 1
Ascoli Piceno 1
Auckland 1
Berlin 1
Braintree 1
Canberra 1
Caselle Torinese 1
Central District 1
Centrale 1
Centreville 1
Chongqing 1
Clarks Summit 1
Düsseldorf 1
Edinburgh 1
Grugliasco 1
Guiyang 1
Hangzhou 1
Hefei 1
Helsinki 1
Los Angeles 1
Madrid 1
Medellín 1
Milan 1
Munich 1
Norwalk 1
Palermo 1
Paris 1
Portland 1
Pozzuoli 1
Richmond 1
Rochester 1
Seoul 1
Sousse 1
São Paulo 1
Tokyo 1
Trieste 1
Verona 1
Wigan 1
Wuhan 1
Yuseong-gu 1
Totale 623
Nome #
IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies 405
Identification of a new subclass of ALK negative ALCL expressing aberrant levels of ERBB4 transcripts 162
ALK expression favorably impacts the prognosis of NRAS-mutated metastatic melanomas 106
Wild-type idh enzymes as actionable targets for cancer therapy 80
ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells 31
ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer 21
Biomimetic mesoporous vectors enabling the efficient inhibition of wild-type isocitrate dehydrogenase in multiple myeloma cells 14
Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma 11
Totale 830
Categoria #
all - tutte 2.247
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.247


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020104 0 0 0 0 8 12 25 14 14 14 7 10
2020/2021166 13 18 7 5 22 15 11 11 14 22 15 13
2021/2022115 4 12 14 8 4 3 7 3 13 14 20 13
2022/2023155 16 22 4 17 11 32 4 7 19 7 12 4
2023/202488 6 10 6 2 3 12 5 14 0 10 12 8
2024/202592 6 24 7 23 32 0 0 0 0 0 0 0
Totale 830